Moderna says its RNA vaccine was nearly 84% effective in preventing symptoms in adults 60 and older

Moderna says its RNA vaccine was nearly 84% effective in preventing symptoms in adults 60 and older

Moderna said a late-stage trial found that its vaccine for respiratory syncytial virus was 84% effective in preventing at least two symptoms in adults ages 60 and older…
Read More
Leave your comment